Kristin, a BRCA1 mutation carrier, was diagnosed with aggressive triple negative breast cancer just one week after her 28th birthday. Fortunately, Kristin’s case was caught very early, and a treatment regimen of chemotherapy and surgery left her disease free. Kristin merged her graduate education in immunology with her passion for advancing cancer therapy and now works at the University of Washington and Fred Hutchinson Cancer Research Center to develop immunotherapy treatments for ovarian cancer patients. She joined the Rivkin Center team as an Instructor and Survivor Speaker to raise awareness about the value of early detection and to empower others to be confident self-advocates with respect to healthcare.